Cipollone Paula
Known title: See RemarksCIK: 0001993631
Associated companies
Transaction History
| LFST | ▼ Sell | Open Market | 48,278 | $349K | 5/13/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 2,000 | $14K | 5/10/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 13,996 | $97K | 3/11/2024 | View on chart |
| LFST | ▲ Buy | Grant | 62,413 | $0 | 3/8/2024 | View on chart |
| LFST | ▲ Buy | Grant | 32,052 | $0 | 3/8/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 3,369 | $25K | 1/3/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.